Emphysema: Difference between revisions
No edit summary |
|||
| Line 9: | Line 9: | ||
== Epidemiology == | == Epidemiology == | ||
<div> | |||
Emphysema is generally found in those less than 40 years old, and more frequently found in those of Scandinavian decent, commonly developing in the 3rd to 5th decade of a life <ref>Banasik 2001; Hough 2014</ref> (Banasik 2001; Hough 2014). The disease tends to express no signs and symptoms until 50% of lung function is lost, as a result of the airway obstructions beginning in the smaller airways <ref>Hough 2014</ref> (Hough 2014). 1% of cases of emphysema are thought to be due to the deficiency of the alpha1-antitrypsin enzyme <ref>Haas &amp; Haas 2000</ref> (Haas & Haas, 2000). | |||
<span style="line-height: 1.5em; font-size: 13.2799997329712px;">The statistics relating to Emphysema are usually held within the wider spectrum of COPD, causing death to more than 14 million Americans, it is thought to be the fourth leading cause of deaths in America <ref>Mattison &amp; Christensen 2006</ref> (Mattison & Christensen, 2006). Within England and Wales, 1.5 million people are said to be affected by Emphysema being within the top 5 leading causes of death <ref>Health and Safety Executive 2005</ref> (Health and Safety Executive, 2005).</span> | |||
<br> | |||
</div> | |||
== Aetiology== | == Aetiology== | ||
Revision as of 13:58, 24 May 2015
Original Editors - Students from Glasgow Caledonian University's Cardiorespiratory Therapeutics Project.
Top Contributors - Valentina Mazzoni, Lucinda hampton, Esraa Mohamed Abdullzaher, Kim Jackson, Admin, WikiSysop, 127.0.0.1, Evan Thomas, Michelle Lee, Uchechukwu Chukwuemeka and Mohit Chand
Definition/Description[edit | edit source]
Definition of the disease or condition
Epidemiology[edit | edit source]
Emphysema is generally found in those less than 40 years old, and more frequently found in those of Scandinavian decent, commonly developing in the 3rd to 5th decade of a life [1] (Banasik 2001; Hough 2014). The disease tends to express no signs and symptoms until 50% of lung function is lost, as a result of the airway obstructions beginning in the smaller airways [2] (Hough 2014). 1% of cases of emphysema are thought to be due to the deficiency of the alpha1-antitrypsin enzyme [3] (Haas & Haas, 2000).
The statistics relating to Emphysema are usually held within the wider spectrum of COPD, causing death to more than 14 million Americans, it is thought to be the fourth leading cause of deaths in America [4] (Mattison & Christensen, 2006). Within England and Wales, 1.5 million people are said to be affected by Emphysema being within the top 5 leading causes of death [5] (Health and Safety Executive, 2005).
Aetiology[edit | edit source]
Pathophysiology[edit | edit source]
Investigations[edit | edit source]
This may well include any investigations used to gain a diagnosis or that you might need to gain information about your patient assessment.
Clinical Manifestations[edit | edit source]
Clinical manifestations (the signs and symptoms your patient may well present to you on an examination) ensure you relate this back to the underlying pathophysiology.
Physiotherapy and Other Management[edit | edit source]
Physiotherapy and other management. Other health professionals will be treating your patient. What is their input?
Prevention[edit | edit source]
Brief consideration of how this pathology could be prevented and the physiotherapy role in health promotion in relation to prevention of disease or disease progression.
Resources
[edit | edit source]
add appropriate resources here
Recent Related Research (from Pubmed)[edit | edit source]
see tutorial on Adding PubMed Feed
Extension:RSS -- Error: Not a valid URL: addfeedhere|charset=UTF-8|short|max=10
